Literature DB >> 29850758

Role of the carboxy groups of triterpenoids in their inhibition of the nucleation of amyloid β42 required for forming toxic oligomers.

Kazuma Murakami1, Takuya Yoshioka, Shiori Horii, Mizuho Hanaki, Satohiro Midorikawa, Shinji Taniwaki, Hiroki Gunji, Ken-Ichi Akagi, Taiji Kawase, Kenji Hirose, Kazuhiro Irie.   

Abstract

Herein we report that a preferable inhibition of the nucleation phase of Aβ42, related to the formation of toxic oligomers, by triterpenoids from medicinal herbs originates from a salt bridge of their carboxy groups with Lys16 and 28 in Aβ42. Such a direct interaction targeting the monomer, dimer, and trimer suppressed further oligomerization. In contrast, the corresponding congeners without carboxy groups failed to do so.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29850758     DOI: 10.1039/c8cc03230k

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  4 in total

1.  Steroid-Quinoline Hybrids for Disruption and Reversion of Protein Aggregation Processes.

Authors:  Hélio M T Albuquerque; Raquel Nunes da Silva; Marisa Pereira; André Maia; Samuel Guieu; Ana Raquel Soares; Clementina M M Santos; Sandra I Vieira; Artur M S Silva
Journal:  ACS Med Chem Lett       Date:  2022-02-14       Impact factor: 4.345

Review 2.  Three Structural Features of Functional Food Components and Herbal Medicine with Amyloid β42 Anti-Aggregation Properties.

Authors:  Kazuma Murakami; Kazuhiro Irie
Journal:  Molecules       Date:  2019-06-05       Impact factor: 4.411

Review 3.  Natural Compounds as Inhibitors of Aβ Peptide Aggregation: Chemical Requirements and Molecular Mechanisms.

Authors:  Katiuscia Pagano; Simona Tomaselli; Henriette Molinari; Laura Ragona
Journal:  Front Neurosci       Date:  2020-12-22       Impact factor: 4.677

4.  Synthetic and biochemical studies on the effect of persulfidation on disulfide dimer models of amyloid β42 at position 35 in Alzheimer's etiology.

Authors:  Kazuma Murakami; Haruka Kato; Mizuho Hanaki; Yoko Monobe; Ken-Ichi Akagi; Taiji Kawase; Kenji Hirose; Kazuhiro Irie
Journal:  RSC Adv       Date:  2020-05-21       Impact factor: 3.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.